1-methyl-2, 3-dihydro-indole-5-carboxylic acid (N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl) ethyl])amide | 256935-66-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-methyl-2, 3-dihydro-indole-5-carboxylic acid (N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl) ethyl])amide
• 英文别名: N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-1-methyl-2,3-dihydroindole-5-carboxamide
• CAS: 256935-66-7
• 化学式: C₂₁H₂₆N₂O₅
• 分子量: 386.448
• InChiKey: XDRCUAJDWVKDDG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  80.3
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  1-methyl-2, 3-dihydro-indole-5-carboxylic acid (N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl) ethyl])amide 在 methoxycarbonylsulfamoyl-triethylammmonium hydroxide 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 以25 mg的产率得到2-(1-Methyl-2,3-dihydroindol-5-yl)-5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-1,3-oxazole
  参考文献：
  名称：

  New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

  摘要：

  During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resistant and multi-drug-resistant cancer cell lines, but its utility in vivo was limited by a short half-life. Medicinal chemistry efforts led to the discovery of indolyloxazoline 22g (A-259745), which maintained all of the in vitro activity seen with oxadiazoline 1, but also demonstrated a better pharmacokinetic profile, and dose-dependent in vivo activity. Over a 28 day study, indolyloxazoline 22g increased the life span of tumor-implanted mice by up to a factor of 3 upon oral dosing. This compound, and others of its structural class, may prove to be useful in the development of new chemotherapeutic agents to treat human cancers.

  DOI：

  10.1021/jm010231w
• 作为产物：
  描述：

  吲哚-5-羧酸 在 N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]amide 、 sodium cyanoborohydride 、 溶剂黄146 、 N,N'-羰基二咪唑 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 21.0h， 生成 1-methyl-2, 3-dihydro-indole-5-carboxylic acid (N-[2-hydroxy-2-(3,4,5-trimethoxyphenyl) ethyl])amide
  参考文献：
  名称：

  New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

  摘要：

  During a screen for compounds that could inhibit cell proliferation, a series of new tubulin-binding compounds was identified with the discovery of oxadiazoline 1 (A-105972). This compound showed good cytotoxic activity against non-multi-drug-resistant and multi-drug-resistant cancer cell lines, but its utility in vivo was limited by a short half-life. Medicinal chemistry efforts led to the discovery of indolyloxazoline 22g (A-259745), which maintained all of the in vitro activity seen with oxadiazoline 1, but also demonstrated a better pharmacokinetic profile, and dose-dependent in vivo activity. Over a 28 day study, indolyloxazoline 22g increased the life span of tumor-implanted mice by up to a factor of 3 upon oral dosing. This compound, and others of its structural class, may prove to be useful in the development of new chemotherapeutic agents to treat human cancers.

  DOI：

  10.1021/jm010231w

文献信息

• Oxazoline antiproliferative agents
  申请人：Abbott Laboratories

  公开号：US06228868B1

  公开（公告）日：2001-05-08

  Compounds having Formula I are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of treating cancer in a mammal.

  具有化学式I的化合物对治疗癌症有用。还公开了包含化学式I化合物的药物组合物，以及在哺乳动物中治疗癌症的方法。